AKT1 and neoplasm: Mechanistically, miR-182-5p reduces expression of CKLF like MARVEL transmembrane domain containing 7 (CMTM7) tumour suppressor, leading to activation of EGFR/AKT signalling and subsequent angiogenic signalling, which was confirmed in vivo [115].